HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.

AbstractPURPOSE:
To test the prognostic potential of tumor R2* with respect to radiotherapeutic outcome. Blood oxygenation level dependent (BOLD) MRI images are sensitive to changes in deoxyhemoglobin concentration through the transverse MRI relaxation rate R2* of tissue water, hence the quantitative measurement of tumor R2* may be related to tissue oxygenation.
METHODS AND MATERIALS:
Tumor growth inhibition in response to radiation was established for both GH3 prolactinomas and RIF-1 fibrosarcomas with animals breathing either air or carbogen during radiation. In a separate cohort, the baseline R2* and carbogen (95% O2, 5% CO2)-induced DeltaR2* of rat GH3 prolactinomas and murine RIF-1 fibrosarcomas were quantified using multigradient echo (MGRE) MRI prior to radiotherapy, and correlated with subsequent tumor growth inhibition in response to ionizing radiation, while the animals breathed air.
RESULTS:
A radiation dose of 15 Gy caused pronounced growth delay in both tumor models and transient regression of the GH3 prolactinomas. When the animals breathed carbogen during radiation, the growth delay/regression was enhanced only in the GH3 prolactinomas. The GH3 prolactinomas, which exhibit a relatively fast baseline R2* and large DeltaR2* in response to carbogen breathing prior to radiotherapy, showed a substantial reduction in normalized tumor volume to 66 +/- 3% with air breathing and 36 +/- 5% with carbogen seven days after 15 Gy irradiation. In contrast, the effect of 15 Gy on the RIF-1 fibrosarcomas, which give a relatively slow baseline R2* and negligible DeltaR2* response to carbogen prior to treatment, showed a much smaller growth inhibition (143 +/- 3% with air, 133 +/- 12% with carbogen).
CONCLUSION:
Quantitation of tumor R2* and carbogen-induced DeltaR2* by MGRE MRI provides completely noninvasive prognostic indicators of a potential acute radiotherapeutic response.
AuthorsLoreta M Rodrigues, Franklyn A Howe, John R Griffiths, Simon P Robinson
JournalJournal of magnetic resonance imaging : JMRI (J Magn Reson Imaging) Vol. 19 Issue 4 Pg. 482-8 (Apr 2004) ISSN: 1053-1807 [Print] United States
PMID15065173 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2004 Wiley-Liss, Inc.
Chemical References
  • Radiation-Sensitizing Agents
  • Carbon Dioxide
  • carbogen
  • Oxygen
Topics
  • Animals
  • Carbon Dioxide (administration & dosage)
  • Female
  • Fibrosarcoma (metabolism, pathology, radiotherapy)
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging (methods)
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Transplantation
  • Oxygen (administration & dosage, metabolism)
  • Prognosis
  • Prolactinoma (metabolism, pathology, radiotherapy)
  • Radiation-Sensitizing Agents (administration & dosage)
  • Radiotherapy Dosage
  • Rats
  • Rats, Inbred WF

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: